New hope for kids battling tough leukemia
NCT ID NCT07306832
Summary
This study is testing a new drug called pivekimab sunirine in children and teenagers whose acute myeloid leukemia (AML) has come back or hasn't responded to other treatments. The main goals are to check the drug's safety and see how it moves through the body. About 18 participants worldwide will receive the drug through an IV to help researchers find a safe dose.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.